>>> BMY -7% Bristol-Myers follow up: BMY down 7% following Opdivo data -- Hearing ISI out cautious regarding low PDL1 expression, opens up competition... MRK, RHHBY lifting (64.24 -4.91) Stock just fell through support at the $64 level.